FMP

FMP

Enter

VCEL - Vericel Corporation

Valuation of Vericel Corporation(VCEL), Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, developm

photo-url-https://financialmodelingprep.com/image-stock/VCEL.png

Vericel Corporation

VCEL

NASDAQ

Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for the repair of symptomatic, and single or multiple full-thickness cartilage defects of the knee; and Epicel, a permanent skin replacement humanitarian use device for the treatment of adult and pediatric patients with deep-dermal or full-thickness burns. Its preapproval stage product is NexoBrid, a registration-stage biological orphan product for eschar removal in adults with deep partial-thickness and/or full-thickness thermal burns. The company was formerly known as Aastrom Biosciences, Inc. Vericel Corporation was incorporated in 1989 and is headquartered in Cambridge, Massachusetts.

47.2 USD

-1.5 (-3.18%)

Valuation Date:

Apr 16, 2024 12:38 PM

Share Price on Valuation Date

$47.2

Stock Beta

1.729

Shares Outstanding

48380500

FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep